[NFS-01] Neuroscience Frontier Symposium 01「Exploring Early Clinical Development through Innovative Drug Modalities」

[NFS-01-2] Developing a new HDO technology using morpholino oligomer to regulate gene expression

Tetsuya Nagata^1,2 (1.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan, 2.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)

2022-Current
Professor, NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University
2018-2022
Research Associate Professor, Department of Neurology, Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2014-2018
Research Senior Assistant Professor, Department of Neurology, Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2009-2014
Section chief, Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry
2008
Assistant Professor, Department of Neurology, Okayama University School of Medicine
2005-2008
Postdoctoral fellow, Department of Neurology/Center for Motor Neuron Biology and Disease, Columbia University
2003-2005
Assistant Professor, Department of Neurology, Okayama University School of Medicine
1999
Graduated from Tohoku University Graduate School
1994
Graduated from Tohoku University School of Medicine